Novavax, Inc.NVAXNASDAQ
Loading
NVAX Revenue Growth (YoY Quarterly)•+66.61%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
+66.61%
+83.3pp
+136.12%
+31.2pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+1.09%
-0.3pp
+8.03%
+6.6pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -69.69% | +610.30% | -42.42% | -16.64% | +66.61% |
| Gross Profit Growth | -63.75% | +1348.61% | -39.06% | +104.87% | +136.12% |
| EBITDA Growth | +0.00% | +0.00% | -32.98% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | -34.37% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | -34.41% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | -40.54% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | -39.39% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +29.56% | +15.10% | +9.19% | +1.44% | +1.09% |
| Weighted Average Shares Diluted Growth | +29.56% | +26.95% | +6.85% | +1.44% | +8.03% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | -140.56% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | -141.04% | +0.00% | +0.00% |
| Receivables Growth | -63.57% | +108.19% | +605.17% | -64.01% | -1.70% |
| Inventory Growth | -79.02% | -34.95% | +11.64% | +56.41% | +31.96% |
| Asset Growth | -13.19% | -4.47% | -26.51% | -31.10% | -24.60% |
| Book Value per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Debt Growth | +0.58% | -0.29% | -2.04% | +7.64% | +7.98% |
| R&D Expense Growth | -36.62% | -4.04% | -27.41% | +12.75% | -29.13% |
| SG&A Expenses Growth | -49.53% | -41.57% | -59.91% | -55.26% | -65.61% |
1 / 4